^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    DOCK8 mutation

    i
    Other names: DOCK8, Dedicator Of Cytokinesis 8, ZIR8, Dedicator Of Cytokinesis Protein 8, FLJ00026, FLJ00152, FLJ00346, Epididymis Luminal Protein 205, 1200017A24Rik, HEL-205, MRD2
    Entrez ID:
    81704
    1year
    A systematic review regarding the prevalence of malignancy in patients with the hyper-IgE syndrome. (PubMed, Clin Exp Med)
    The results of this study indicated that in 6.5% of cases, HIES was complicated with malignancy, and considering the higher rate of these malignancies in women as well as in DOCK8 mutation sufferers, it is necessary for physicians to be aware of this association and includes malignancy screening in follow-up and periodic examinations of these patients. Indeed, more studies in this field will help to clarify the precise figures and predisposing factors of the relationship between HIES and malignancy.
    Review • Journal
    |
    STAT3 (Signal Transducer And Activator Of Transcription 3) • TYK2 (Tyrosine Kinase 2) • DOCK8 (Dedicator Of Cytokinesis 8)
    |
    STAT3 mutation • DOCK8 mutation